By Mill Chart
Last update: Jun 13, 2025
ADMA BIOLOGICS INC (NASDAQ:ADMA) has been identified as a high-growth momentum stock that aligns with Mark Minervini’s Trend Template. The company, a biopharmaceutical firm specializing in plasma-derived biologics, demonstrates strong technical and fundamental characteristics that make it a compelling candidate for growth-focused investors.
Minervini’s strategy focuses on stocks with strong upward momentum, confirmed by key technical indicators. ADMA meets these criteria:
ADMA’s financials reflect accelerating growth, a critical factor for high-growth investors:
ADMA’s technical rating of 10/10 highlights its strong trend, though the current setup rating of 5 suggests waiting for a consolidation before entry. Key support levels are found at $20.18-$20.31 and $19.20, providing potential downside protection.
Our High Growth Momentum + Trend Template screener lists more stocks with similar growth and momentum traits.
For a deeper technical analysis, review the full ADMA technical report.
This is not investment advice. Always conduct your own research and consider risk management before making investment decisions.
NASDAQ:ADMA (10/16/2025, 2:43:54 PM)
14.665
-0.43 (-2.82%)
Find more stocks in the Stock Screener